Results 81 to 90 of about 55,562 (265)

Fault Current Limitation in Electrical Power Networks Containing HTS Cable and HTS Fuse. [PDF]

Materials (Basel), 2022
Degtyarenko PN, Zheltov VV, Balashov NN, Arkhangelsky AY, Degtyarenko AY, Kovalev KL.   +5 more
europepmc   +1 more source

CCDC80 suppresses high‐grade serous ovarian cancer migration via negative regulation of B7‐H3

Molecular Oncology, EarlyView.
PAX8 is a lineage‐specific master regulator of transcription in high‐grade serous ovarian cancer (HGSC) progression. We show for the first time that PAX8 facilitates proliferation and metastasis by repressing the cell autonomous tumor suppressor CCDC80 and inducing B7‐H3 expression.
Aya Saleh, Nitzan Medina‐Itzhaki, Milena Chekov, Eden Gal‐Swisa, Roba Gabesh‐Wahabi, Inbar Savyon, Inna Naroditsky, Hilary A. Kenny, Basem Fares, Lina Korsensky, Einav Girsh, Liron Berger, Ruth Perets   +12 more
wiley   +1 more source

A New Criterion for Transformer Excitation Inrush Current Identification Based on the Wasserstein Distance Algorithm

Energies
To circumvent the computational bottlenecks associated with the intermediate steps (e.g., least squares fitting) in conventional sine wave similarity principles and directly acquire the energy metrics required for stabilized sinusoidal waveform ...
Shanshan Zhou, Jingguang Huang, Yuanning Zhang, Yulong Li   +3 more
doaj   +1 more source

Quenched Flux-Coupling Superconducting Fault Current Limiter Scheme and Its Electromagnetic Design Method. [PDF]

Materials (Basel), 2023
Yan S, Ren L, Zhao J, Xu Y, Shen S, Xiong Y, Liu B, Xiao F.   +7 more
europepmc   +1 more source

CD47 promotes mitogen‐activated protein kinase and epithelial‐to‐mesenchymal transition molecular programs to drive prometastatic phenotypes in non‐small cell lung cancer

Molecular Oncology, EarlyView.
Beyond its role in immune evasion, this study identified that CD47 drives tumor‐intrinsic signaling in non‐small cell lung cancer (NSCLC). Transcriptomic profiling and functional studies revealed that CD47 regulates cell adhesion, migration, and metastasis through an ERK–EMT signaling axis.
Asa P.Y. Lau, Lilian G. Zhai, Ryunosuke Hoshi, Zackary Rousseau, Abraam Zakhary, Yin Fang Wu, Rola M. Saleeb, Heyu Ni, Kelsie L. Thu   +8 more
wiley   +1 more source

Research on mechanical flux weakening performance of permanent magnet synchronous motors based on sliding magnetic bridges

机车电传动
To address the increased heating and vibration caused by the inability to regulate the magnetic field of permanent magnet synchronous motors (PMSMs) used in rail transit under fault conditions, this paper proposes a magnetic-field-adjustable PMSM based ...
DUAN Rong, HOU Xiaojun, PANG Cong, WU Nan, NI Wei, ZHANG Sha   +5 more
doaj  

A Hybrid DC Circuit Breaker with Fault-Current-Limiting Capability for VSC-HVDC Transmission System

Energies, 2019
The direct current circuit breakers are considered a promising option to protect the transmission line against commonly appearing line-to-ground fault.
Muhammad Ahmad, Zhixin Wang
doaj   +1 more source

Combining finite element and reinforcement learning methods to design superconducting coils of saturated iron-core superconducting fault current limiter in the DC power system. [PDF]

PLoS One, 2023
Kim CS, Dao VQ, Park J, Jang B, Lee SJ, Park M.   +5 more
europepmc   +1 more source

Fault Current Limitation by a Superconducting Coil with a Reversely Magnetized Core for a Fault Current Controller

Progress in Superconductivity and Cryogenics, 2012
This paper presents an experimental and numerical study on current limiting characteristics of a fault current controller (FCC). The FCC consists of an AC/DC power converter, a superconducting coil, and a control unit. Even though some previous researches proved that the FCC could adjust the fault current level, the current limiting characteristics by ...
Min Cheol Ahn, Tae Kuk Ko
openaire   +2 more sources

KDM7A and KDM1A inhibition suppresses tumour promoting pathways in prostate cancer

Molecular Oncology, EarlyView.
Treatment resistance is a major challenge for patients with advanced prostate cancer. This study examined an alternative approach to target the major prostate cancer‐promoting pathway by targeting epigenetic factors, whose levels are higher in tumours.
Jennie N Jeyapalan, Veronika M Metzler, Simone de Brot, Corinne L Woodcock, Anna E Harris, Jennifer Lothion‐Roy, Emeli M Nilsson, Atara Ntekim, Michael S Toss, Jenny L Persson, Francesca Khani, Brian D Robinson, Lorraine J Gudas, Emad Rakha, David M Heery, Catrin S Rutland, Nigel P Mongan   +16 more
wiley   +1 more source